Your browser doesn't support javascript.
loading
Case Report: A Case of Adult Methylmalonic Acidemia With Bilateral Cerebellar Lesions Caused by a New Mutation in MMACHC Gene.
Wang, Shengnan; Wang, Xu; Xi, Jianxin; Yang, Wenzhuo; Zhu, Mingqin.
Afiliação
  • Wang S; Department of Neurology, The First Hospital of Jilin University, Changchun, China.
  • Wang X; Department of Neurology, The First Hospital of Jilin University, Changchun, China.
  • Xi J; Clinical College, Jilin University, Changchun, China.
  • Yang W; Clinical College, Jilin University, Changchun, China.
  • Zhu M; Department of Neurology, The First Hospital of Jilin University, Changchun, China.
Front Neurol ; 13: 935604, 2022.
Article em En | MEDLINE | ID: mdl-35865640
ABSTRACT
Methylmalonic acidemia is a severe heterogeneous disorder of methylmalonate and cobalamin (Cbl; vitamin B12) metabolism with poor prognosis. Around 90% of reported patients with methylmalonic acidemia (MMA) are severe infantile early onset, while cases with late-onset MMA have been rarely reported. Few reported late-onset MMA patients presented with atypical clinical symptoms, therefore, often misdiagnosed if without family history. Herein, we report a 29-year-old female who was admitted to our hospital due to symptoms manifested as encephalitis. The brain MRI showed symmetrical bilateral cerebellar lesions with Gd enhancement. Laboratory tests showed significantly elevated levels of homocysteine and methylmalonic acid. A genetic analysis identified a novel homozygous mutation (c.484G>A; p.Gly162 Arg) in the MMACHC gene. The patient was diagnosed with MMA, and her symptoms improved dramatically with intramuscular adenosine cobalamin treatment. In conclusion, for patients with symmetrical lesions in the brain, the possibility of metabolic diseases should be considered, detailed medical and family history should be collected, and metabolic screening tests as well as gene tests are necessary for correct diagnosis. The mutation diversity in MMACHC gene is an important factor leading to the heterogeneity of clinical manifestations of patients with MMA.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article